aap Implantate Aktie
| 1,46EUR | -0,09EUR | -5,81% |
WKN DE: A3H210 / ISIN: DE000A3H2101
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 102 | 109 | 117 | 101 | 93 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,09 | 0,11 | 0,10 | 0,11 | 0,13 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 10 | 13 | 11 | 9 | 9 |
| Summe Anlagevermögen | 9 | 10 | 10 | 11 | 7 |
| Summe Aktiva | 20 | 23 | 21 | 19 | 16 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 9 | 11 | 8 | 9 | 5 |
| Summe Eigenkapital | 10 | 13 | 13 | 11 | 10 |
| Summe Passiva | 20 | 23 | 21 | 19 | 16 |
Adresse
| Lorenzweg 5, 12099 Berlin | |
| Telefon | +49 (30) 75019-0 |
| Internet | http://aap.de |
Management
|
Jacqueline P. Rijsdijk
Vice Chairman-Supervisory Board |
|
Marc Langner
Member-Supervisory Board |
|
Nathalie Krebs
Chairman-Supervisory Board |
|
Rubino di Girolamo
Chief Executive Officer |
|
Torbjörn Sköld
Member-Supervisory Board |